About Imaginostics

About company

Imaginostics is a Boston-based health tech startup developing breakthrough magnetic resonance imaging (MRI) technology for precision medicine. The company’s proprietary QUTE-CE MRI methodology provides biomarkers with their software that can non-invasively assay vascular structure and function in high resolution anywhere in the body, providing clinicians and scientists new endpoints for early detection and enhanced characterization of complex diseases. Imaginostics creates innovative, non-invasive diagnostic solutions using their breakthrough quantitative imaging biomarkers to provide new insight into health and disease. The company primarily provides clinicians with only qualitative, contrast-based images.